The present invention relates to solid oral pharmaceutical compositions of linaclotide for once daily administration, preferably as unit dosage form or plurality of units filled into capsule or compressed to form tablet or combinations thereof. The compositions described herein have a sufficient shelf life for manufacturing, storing and distributing the drug.